Modification‐Response Integrated Modules Driven Cyclization‐Dependent Prodrug Self‐Assembly for Reshaping Pro‐Apoptotic Tumor Redox Homeostasis
Exploration · 2026-04 · 6 (2)
DOI: 10.1002/exp.20240448 ↗Kurz gefasst
Fachartikel in der Zeitschrift Exploration, online erschienen am 10.03.2026. Verfasst von Yixin Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics Wuya College of Innovation Shenyang Pharmaceutical University Shenyang China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Shenyang Young and Middle-aged Science and Technology Innovation Talent Support Program.
Abstract (Originalsprache)
Affected by the complexity and heterogeneity of the tumor redox microenvironment, chemotherapy often fails to achieve satisfactory clinical outcomes. Modular design of prodrug nanoassemblies presents tremendous potential in upgrading the therapeutic index of chemotherapeutic agents. Given the biochemical vulnerability of tumor redox homeostasis, we fabricated five‐membered cyclic chalcogenide‐linked paclitaxel prodrug nanoassemblies, which realized tumor site‐specific activation and reshaped the pro‐apoptotic tumor redox homeostasis. Cyclic diselenide and cyclic disulfide bonds integrated the modification modules and response modules to minimize the utilization of non‐pharmacodynamic moieties and increase druggability. Importantly, the modification‐response integrated modules could simultaneously block the glutathione‐glutathione peroxidase (GSH/GPx) antioxidant system and amplify reactive oxygen species (ROS) generation. The reshaping of the tumor redox homeostasis cascade triggered the loss of mitochondrial membrane potential and apoptosis of tumor cells, which synergistically potentiated the antitumor effects of paclitaxel. Such an intelligent prodrug nanoplatform brought new perspectives for constructing advanced antitumor nanomedicines with significant clinical research value.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutics Wuya College of Innovation Shenyang Pharmaceutical University Shenyang China.
- Department of Pharmacy The First Affiliated Hospital of Jinzhou Medical University Jinzhou China.
- Leicester School of Pharmacy De Montfort University Leicester UK.
- Joint International Research Laboratory of Intelligent Drug Delivery Systems Ministry of Education,Shenyang Pharmaceutical University Shenyang China.
ORCID-Profile: Bingjun Sun, Jin Sun
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Shenyang Young and Middle-aged Science and Technology Innovation Talent Support Program
Zitieren
APA
Sun, Y., Zuo, S., Zang, W., Li, L., Shi, X., Li, M., He, Z., Sun, B., & Sun, J. (2026). Modification‐Response Integrated Modules Driven Cyclization‐Dependent Prodrug Self‐Assembly for Reshaping Pro‐Apoptotic Tumor Redox Homeostasis. Exploration, 6(2). https://doi.org/10.1002/exp.20240448
Vancouver
Sun Y, Zuo S, Zang W, Li L, Shi X, Li M, et al. Modification‐Response Integrated Modules Driven Cyclization‐Dependent Prodrug Self‐Assembly for Reshaping Pro‐Apoptotic Tumor Redox Homeostasis. Exploration. 2026;6(2). doi:10.1002/exp.20240448
BibTeX
@article{Sun2026,
author = {Sun, Yixin and Zuo, Shiyi and Zang, Wenfeng and Li, Lingxiao and Shi, Xianbao and Li, Mingzhong and He, Zhonggui and Sun, Bingjun and Sun, Jin},
title = {Modification‐Response Integrated Modules Driven Cyclization‐Dependent Prodrug Self‐Assembly for Reshaping Pro‐Apoptotic Tumor Redox Homeostasis},
journal = {Exploration},
year = {2026},
volume = {6},
number = {2},
doi = {10.1002/exp.20240448}
}
EUVIMED